Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention

Use of Lipid-lowering Agents in Rheumatoid Arthritis: A Population-based Cohort Study

(2013) B. M. Akkara Veetil et al.   JOURNAL OF RHEUMATOLOGY

Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis

(2013) A. G. Semb et al.   JOURNAL OF RHEUMATOLOGY

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study

(2012) Jesper Lindhardsen et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic

(2012) Silvia Rollefstad et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

(2012) Anne Grete Semb et al.   ARTHRITIS AND RHEUMATISM

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

(2012) Joep Perk et al.   ATHEROSCLEROSIS

The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study

(2011) J. Lindhardsen et al.   ANNALS OF THE RHEUMATIC DISEASES

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

(2011) E. Myasoedova et al.   ANNALS OF THE RHEUMATIC DISEASES

Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?

(2010) Tracey E. Toms et al.   ANGIOLOGY

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

(2010) A. G. Semb et al.   ANNALS OF THE RHEUMATIC DISEASES

Dyslipidaemia in Rheumatoid Arthritis: The Role of Inflammation, Drugs, Lifestyle and Genetic Factors

(2010) Tracey E. Toms et al.   Current Vascular Pharmacology

The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better

(2010) M. J. L. Peters et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study

(2010) O. Ahlehoff et al.   JOURNAL OF INTERNAL MEDICINE

Effect of Atorvastatin on Inflammation and Modification of Vascular Risk Factors in Rheumatoid Arthritis

(2010) A. M. EL-BARBARY et al.   JOURNAL OF RHEUMATOLOGY

Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins

(2010) Radjesh J. Bisoendial et al.   Nature Reviews Rheumatology

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

(2010) Anne G. Semb et al.   RHEUMATOLOGY

Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis

(2010) Sylvain Mathieu et al.   ARTHRITIS CARE & RESEARCH

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

(2009) T. E. Toms et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

(2009) E Choy et al.   ANNALS OF THE RHEUMATIC DISEASES

Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort

(2009) John F. Thompson et al.   Circulation-Cardiovascular Genetics

Analytical performance evaluation of the Cobas 6000 analyzer – special emphasis on trueness verification

(2008) Adriaan J. van Gammeren et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE